Outcome of abdominosacral resection for locally advanced primary and recurrent rectal cancer

British Journal of Surgery

Volumn 99, Issue 10, 2012, Pages 1453-1461

  Bhangu, A ^a,c   Brown, G ^b   Akmal, M ^a,d   Tekkis, P ^a,c  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b Royal Marsden Hospital   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d NATIONAL HEALTH SERVICE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMEN; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ARTICLE; BACK; BLEEDING; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LENGTH OF STAY; MALE; MIDDLE AGED; PROSPECTIVE STUDY; RECTUM TUMOR; STATISTICS; TREATMENT OUTCOME; TUMOR RECURRENCE;

ABDOMEN; BLOOD LOSS, SURGICAL; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; SACROCOCCYGEAL REGION; TREATMENT OUTCOME;

EID: 84866118017     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.8881     Document Type: Article

References (21)

1. Sagar PM, Gonsalves S, Heath RM, Phillips N, Chalmers AG,. Composite abdominosacral resection for recurrent rectal cancer. Br J Surg 2009; 96: 191-196.
2. Ferenschild FT, Vermaas M, Verhoef C, Ansink AC, Kirkels WJ, Eggermont AM, et al., Total pelvic exenteration for primary and recurrent malignancies. World J Surg 2009; 33: 1502-1508.
3. Harris DA, Davies M, Lucas MG, Drew P, Carr ND, Beynon J,. Multivisceral resection for primary locally advanced rectal carcinoma. Br J Surg 2011; 98: 582-588.
4. Ferenschild FT, Vermaas M, Verhoef C, Dwarkasing RS, Eggermont AM, de Wilt JH,. Abdominosacral resection for locally advanced and recurrent rectal cancer. Br J Surg 2009; 96: 1341-1347.
5. MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. Br Med J 2006; 333: 779.
6. Jayne DG, Thorpe HC, Copeland J, Quirke P, Brown JM, Guillou PJ,. Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg 2010; 97: 1638-1645.
7. van Gijn W, Marijnen CA, Nagtegaal ID, Kranenbarg EM, Putter H, Wiggers T, et al., Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 2011; 12: 575-582.
8. Rahbari NN, Ulrich AB, Bruckner T, Munter M, Nickles A, Contin P, et al., Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure? Ann Surg 2011; 253: 522-533.
9. Boyle KM, Sagar PM, Chalmers AG, Sebag-Montefiore D, Cairns A, Eardley I,. Surgery for locally recurrent rectal cancer. Dis Colon Rectum 2005; 48: 929-937.
10. Yamada K, Ishizawa T, Niwa K, Chuman Y, Aikou T,. Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer. Dis Colon Rectum 2002; 45: 1078-1084.
11. Wanebo HJ, Marcove RC,. Abdominal sacral resection of locally recurrent rectal cancer. Ann Surg 1981; 194: 458-471.
12. Melton GB, Paty PB, Boland PJ, Healey JH, Savatta SG, Casas-Ganem JE, et al., Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment results. Dis Colon Rectum 2006; 49: 1099-1107.
13. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP,; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453-1457.
14. Moriya Y, Akasu T, Fujita S, Yamamoto S,. Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer. Surg Oncol Clin N Am 2005; 14: 225-238.
15. Heriot AG, Byrne CM, Lee P, Dobbs B, Tilney H, Solomon MJ, et al., Extended radical resection: the choice for locally recurrent rectal cancer. Dis Colon Rectum 2008; 51: 284-291.
16. Dozois EJ, Privitera A, Holubar SD, Aldrete JF, Sim FH, Rose PS, et al., High sacrectomy for locally recurrent rectal cancer: can long-term survival be achieved? J Surg Oncol 2011; 103: 105-109.
17. Bhangu A, Ali SM, Darzi A, Brown G, Tekkis P,. Meta-analysis of survival based on resection margin status following surgery for recurrent rectal cancer. Colorectal Dis 2012; [Epub ahead of print 22 Feb 2012; DOI: 10.1111/j.1463-1318. 2012.03005].
18. Georgiou P, Tekkis P, Constantinides V, Patel U, Goldin R, Darzi A,. Diagnostic accurary and value of MRI in planning exenterative pelvic surgery for advanced colorectal cancer. J Clin Oncol 2011; 29 (Suppl 4):Abstract 370.
19. Das P, Delclos ME, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, et al., Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation. Int J Radiat Oncol Biol Phys 2010; 77: 60-65.
20. Dresen RC, Gosens MJ, Martijn H, Nieuwenhuijzen GA, Creemers GJ, Daniels-Gooszen AW, et al., Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer. Ann Surg Oncol 2008; 15: 1937-1947.
21. Mannaerts GH, Rutten HJ, Martijn H, Hanssens PE, Wiggers T,. Effects on functional outcome after IORT-containing multimodality treatment for locally advanced primary and locally recurrent rectal cancer. Int J Radiat Oncol Biol Phys 2002; 54: 1082-1088.